Dividing acute-phase serum concentrations of ApoB/ApoA-I into two groups, the cumulative stroke recurrence rate at the end of the 1-year follow-up was 18.3% for ApoB/ApoA-I > median and 9.9% for ApoB/ApoA-I < median, with significantly different cumulative stroke recurrence rates between the two groups (log-rank P-value = 0.001; Figure 1). The gene discussed is APOB; the disease is Stroke.